POET (POET) Stock; Jumps 11% as Lumilens Deal Fuels AI Data Center Growth Narrative

TLDRs;

• POET stock surged 11% as AI data center optics demand narrative strengthens.
• Lumilens partnership boosts long-term optimism despite execution uncertainty and early stage.
• Company remains pre-revenue scale with significant losses and funding reliance.
• Legal class actions and PFIC tax risks continue weighing on sentiment.

POET Technologies Inc. extended its sharp upward momentum this week, with shares jumping about 11% as traders continued to rotate into AI-linked optical networking plays. The move builds on a broader rebound in sentiment toward AI data center infrastructure, where demand for high-speed optical interconnects remains a key theme driving speculative and institutional interest.

The latest surge comes as investors increasingly position POET as a leveraged play on the expansion of AI data centers, where traditional electrical data transmission is struggling to keep up with bandwidth demands. The company’s Optical Interposer technology, which integrates photonic and electronic components into a single chip-scale architecture, is being framed as a potential long-term solution to these bottlenecks.

However, the rally remains heavily sentiment-driven, with the company still operating at early commercialization stages and reporting minimal revenue relative to its market valuation.

Lumilens Partnership Boosts Growth Story

A key catalyst behind the renewed enthusiasm is POET’s supply agreement involving Lumilens, which has become central to the company’s bullish narrative. The deal reportedly begins with an initial $50 million commitment and could scale toward $500 million over several years if performance milestones and production targets are achieved.

POET Technologies Inc., POET

Lumilens executives have emphasized the urgency of improving GPU interconnect performance, arguing that optical solutions will be essential to scaling next-generation AI workloads. That positioning has helped frame POET as part of a critical supply chain for hyperscale data center expansion rather than a standalone semiconductor microcap.

POET leadership has echoed that view, highlighting efforts to bring semiconductor-level manufacturing discipline to optical engine production. The company has also signaled a major expansion plan, including a roughly tenfold increase in wafer production and assembly capacity aimed at supporting commercial scale-up into 2027.

Still, analysts caution that much of the growth story depends on successful execution, qualification cycles, and sustained demand from large-scale AI infrastructure customers.

Financial Reality Still Lags the Narrative

Despite the strong stock performance, POET’s fundamentals continue to show the gap between narrative and execution. The company recently reported quarterly revenue of just over $500,000, alongside a net loss exceeding $12 million, underscoring its pre-scale stage in the commercialization curve.

To support expansion efforts, POET raised approximately $400 million through a combination of share sales and warrants, strengthening its balance sheet but also diluting existing shareholders. Management has indicated that this capital will be directed toward manufacturing scale-up and operational readiness for anticipated demand growth.

Investor enthusiasm is further fueled by long-term projections from research coverage suggesting significant upside potential if the company successfully transitions into mass production. However, those estimates are highly dependent on future revenue milestones that remain unproven.

Legal Pressure and Tax Concerns Add Risk Layer

While momentum is building on the AI optics narrative, POET continues to face material legal and regulatory overhangs. Multiple law firms have filed or advanced securities class action complaints alleging that the company may have issued misleading statements related to business operations, customer agreements, and disclosure practices.

Investors have been given deadlines to seek lead plaintiff status, signaling that litigation risk remains active and unresolved. Although the allegations have not been proven in court, they continue to weigh on sentiment, particularly among institutional investors sensitive to governance risk.

The post POET (POET) Stock; Jumps 11% as Lumilens Deal Fuels AI Data Center Growth Narrative appeared first on CoinCentral.